FUNROOTS Co., Ltd. (Tokyo, Japan), I Peace, Inc. (California, USA), and Reju Inc. (Tokyo, Japan) entered a strategic partnership to integrate cutting-edge iPS cell technology into the sports industry, aiming to deliver innovative health management solutions, enhance athletic performance, and accelerate injury recovery, leveraging advancements in regenerative medicine. [Read more…]
Pioneering the future of sports with iPS cells
Altaris Launches Minaris Advanced Therapies, Merging the CDMOs Minaris Regenerative Medicine and WuXi Advanced Therapies
Combined Entity will be a Global CDMO Powerhouse in Cell and Gene Therapy
In a bold move that has consolidated the landscape of advanced therapy manufacturing, Altaris LLC announced the successful acquisition of two key cell and gene therapy operations—Advanced Therapies U.S. and OXGENE—from WuXi AppTec. Completed on March 7, 2025, the transaction marks a strategic expansion of Altaris’ footprint in the fast-growing cell and gene therapy contract development and manufacturing organization (CDMO) space. [Read more…]
LIfT BioSciences gains access to half a million allogeneic donors through collaboration with Gift of Life Biologics
LIfT BioSciences gains access to half a million allogeneic donors through collaboration with Gift of Life Biologics
London, 03 April 2025 – LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly emerging biotech and the global leader in neutrophil immunotherapies, and Gift of Life Biologics, (‘GOLB’) a leader in the provision of cellular starting material for cell therapies, announce a collaboration with GOLB as LIfT’s preferred partner for sourcing hematopoietic stem cells (HSCs) for the production of its clinical grade Immunomodulatory Alpha Neutrophils (IMANs), a first-in-class cell therapy designed to overcome treatment resistance in solid tumours as the Company prepares to initiate its clinical trials. [Read more…]
How Amazon, Google, And Apple Are Covertly Tackling The Healthcare Sector
Traditionally known for tech products, Amazon, Google, and Apple are beginning covert ventures into yet another critical sphere of human life, healthcare.
With hundreds of thousands of health-related apps available globally, more than 320 million users engaging with these platforms, and over 600 million wearable devices projected to ship annually by 2026, it is no surprise that companies like Google, Apple, and Amazon are investing heavily in cutting-edge healthcare technologies. [Read more…]
Nikon CeLL Innovation Enters into a Strategic License Agreement with RoosterBio, a US Company, to Enable GCTP/GMP Manufacturing Platform of Human Mesenchymal Stem Cells & Extracellular Vesicle in Japan
TOKYO – Nikon CeLL innovation Co., Ltd. (NCLi), a subsidiary of Nikon Corporation has entered into a strategic licensing agreement with RoosterBio, Inc. (RoosterBio), a leading stem cell technology company in the US.
This agreement provides the Japanese biopharma industry with an end-to-end solution for development and manufacturing of human mesenchymal stem cells (MSC) and extracellular vesicle (EV) therapeutics. Drug developers can leverage RoosterBio’s technology platform to accelerate the development of their advanced therapies with NCLi, and then seamlessly transition to clinical manufacturing within NCLi’s GCTP*1/GMP*2 facility designed specifically for cell therapies. [Read more…]
- « Previous Page
- 1
- …
- 54
- 55
- 56
- 57
- 58
- …
- 334
- Next Page »